GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A...
Cistto Founder Li An: 'We Deliver Unique Products to Enhance the Skincare Experience for North American Consumers'
LOS ANGELES, Nov. 26, 2024 /PRNewswire/ -- Cistto, a cutting-edge brand dedicated to repairing sensitive skin, announced their expanding into the North American market. Cistto has quickly captured the hearts of modern travelers in China with its...
Shengfeng Development Limited Reports 107.8% Revenue Increase from China Post Services During 2024 Double 11 Shopping Festival
Revenue g rows from $6.7 million to $13.9 million FUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Shengfeng Development Limited ("Shengfeng" or the "Company") (NASDAQ: SFWL), a contract logistics company in China providing customers with integrated...
Visualsyn's Glinda AIMI Recognized with CES Innovation Award 2025
Streamlined workflows on AI-powered 3D content creation platform make XR accessible, affordable, and scalable for businesses of all sizes LAS VEGAS and SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Visualsyn, a Korean XR production startup,...
Haier Named Official Partner of the Australian Open for 2025-2027
MELBOURNE, Australia, Nov. 25, 2024 /PRNewswire/ -- Haier announced today it is the official TV and Appliance partner of the Australian Open and Summer of Tennis events. The two sides marked the partnership with an announcement ceremony in...
Scienjoy Holding Corporation Reports Nine Months ended September 30, 2024 Unaudited Financial Results
Income from Operations up 313.7% Year Over Year Net Income Increased by Approximately US$10 million Year Over Year BEIJING, Nov. 25, 2024 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive...
Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024
BEIJING, Nov. 25, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended September 30, 2024. Highlights for the Quarter...
Legacy Meets Mindful Luxury at Hakone Sanctuary: Embrace Nature's Finest at Kinnotake Resorts with Black Friday Exclusive
HAKONE, Japan, Nov. 25, 2024 /PRNewswire/ -- Kinnotake Corporation has announced a Black Friday Sale for Kinnotake Resorts, granting exclusive access to three exceptional properties in Hakone, Kanagawa Prefecture. Each resort offers a distinctive...
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
ROCKVILLE, Md. and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its...